temoporfin has been researched along with Minimal Disease, Residual in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dhamiyati, W; Fles, R; Hariwiyanto, B; Haryana, SM; Herdini, C; Indrasari, SR; Karakullukcu, B; Romdhoni, AC; Stoker, SD; Tan, IB; Widayati, K; Wildeman, MA | 1 |
De Boer, JP; Karakullukcu, B; Tan, B; Van Veen, R; Wegman, J | 1 |
Hariwiyanto, B; Herdini, C; Indrasari, SR; Karakullukcu, MB; Tan, IB; Timmermans, AJ; Wildeman, MA | 1 |
1 trial(s) available for temoporfin and Minimal Disease, Residual
Article | Year |
---|---|
Photodynamic therapy as salvage therapy for patients with nasopharyngeal carcinoma experiencing local failures following definitive radiotherapy.
Topics: Adult; Carcinoma; Chemotherapy, Adjuvant; Female; Humans; Kaplan-Meier Estimate; Male; Mesoporphyrins; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Salvage Therapy | 2015 |
2 other study(ies) available for temoporfin and Minimal Disease, Residual
Article | Year |
---|---|
Surgical debulking combined with photodynamic therapy to manage residual extramedullary plasmacytoma of the nasopharynx.
Topics: Disease-Free Survival; Endoscopy; Follow-Up Studies; Humans; Male; Mesoporphyrins; Middle Aged; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Plasmacytoma; Radiotherapy Dosage; Remission Induction | 2011 |
Remarkable response to photodynamic therapy in residual T4N0M0 nasopharyngeal carcinoma: a case report.
Topics: Adult; Carcinoma; Humans; Male; Mesoporphyrins; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents | 2012 |